Cas 5571-46-0,2H-1,4-Benzodiazepin-2-one, 9-chloro-1,3-dihydro-5-phenyl-

5571-46-0

Post Buying Request

Basic information

Product Name: 2H-1,4-Benzodiazepin-2-one, 9-chloro-1,3-dihydro-5-phenyl-
Synonyms:
CAS NO:5571-46-0
Molecular Formula: C15H11ClN2O
Molecular Weight: 270.718
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2H-1,4-Benzodiazepin-2-one, 9-chloro-1,3-dihydro-5-phenyl-(CAS DataBase Reference)
NIST Chemistry Reference: 2H-1,4-Benzodiazepin-2-one, 9-chloro-1,3-dihydro-5-phenyl-(5571-46-0)
EPA Substance Registry System: 2H-1,4-Benzodiazepin-2-one, 9-chloro-1,3-dihydro-5-phenyl-(5571-46-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 5571-46-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

5571-46-0 Suppliers

Recommended suppliers

5571-46-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5571-46-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,7 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5571-46:
(6*5)+(5*5)+(4*7)+(3*1)+(2*4)+(1*6)=100
100 % 10 = 0
So 5571-46-0 is a valid CAS Registry Number.

5571-46-0Upstream product

5571-46-0Downstream Products

820215-03-0 9-chloro-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine

5571-46-0Relevant academic research and scientific papers

BENZODIAZEPINE CGRP RECEPTOR ANTAGONISTS

-

Page 42, (2010/02/10)

The present invention is directed to compounds of Formula I: I (where variables R1, R2, R3, R6, R7, G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 5571-46-0